BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4659043)

  • 1. Murine bladder tumors as models for human tumor immunity.
    Hellström I; Hellström KE
    Natl Cancer Inst Monogr; 1972 Dec; 35():125-7. PubMed ID: 4659043
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
    Perlmann P; O'Toole C; Unsgaard B
    Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
    [No Abstract]   [Full Text] [Related]  

  • 4. Some immunological considerations relevant to the study of human bladder cancer.
    Bean MA
    Cancer Res; 1977 Aug; 37(8 Pt 2):2879-84. PubMed ID: 326394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological studies on urinary bladder tumors of rats and mice.
    Taranger LA; Chapman WH; Hellström I; Hellström KE
    Science; 1972 Jun; 176(4041):1337-40. PubMed ID: 5034547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immune mechanisms of tumor cell destruction.
    Perlmann P; O'Toole C; Unsgaard B
    Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 9. Standardization of microcytotoxicity assay for cell-mediated immunity.
    O'Toole C
    Natl Cancer Inst Monogr; 1973 Jun; 37():19-24. PubMed ID: 4713781
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular immunity and blocking antibodies to tumors.
    Hellström I; Hellström KE
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cellular immunity in mouse plasmocytomas].
    Lespinats G; Poupon MF
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract]   [Full Text] [Related]  

  • 13. The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment.
    O'Toole C; Unsgaard B; Almgård LE; Johansson B
    Br J Cancer Suppl; 1973 Aug; 1():266-75. PubMed ID: 4804285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.
    Bean MA; Bloom BR; Herberman RB; Old LJ; Oettgen HF; Klein G; Terry WD
    Cancer Res; 1975 Oct; 35(10):2902-13. PubMed ID: 1157057
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of cell-mediated immunity to human tumor-associated antigens.
    Baldwin RW; Embeton MJ
    Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantation immunity to individually unique antigens of chemically induced bladder tumors in mice.
    Wahl DV; Chapman WH; Hellström I; Hellström KE
    Int J Cancer; 1974 Jul; 14(1):114-21. PubMed ID: 4142461
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cellular immunity to tumor antigens].
    Hellström KE; Hellström I
    Lakartidningen; 1974 Feb; 71(6):473-8. PubMed ID: 4837237
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymph node reactivity to experimental bladder tumor in preimmunized animals as measured by two parameter flow cytometry.
    Collste LG; Kostyrka-Claps ML; Darzynkiewicz Z; Devonec M; Traganos F; Whitmore WF; Melamed MR
    Invest Urol; 1979 Nov; 17(3):191-4. PubMed ID: 500314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum factors modifying cellular immune responses to growing tumours.
    Baldwin RW; Price MR; Robins RA
    Br J Cancer Suppl; 1973 Aug; 1():37-47. PubMed ID: 4374231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the immunobiology of human bladder cancer.
    Herr HW
    Clin Bull; 1975; 5(4):149-53. PubMed ID: 776446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.